VRBCF saw its Momentum Indicator move below the 0 level on December 12, 2024. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 9 similar instances where the indicator turned negative. In of the 9 cases, the stock moved further down in the following days. The odds of a decline are at .
The Aroon Indicator entered an Uptrend today. In of 69 cases where VRBCF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.585) is normal, around the industry mean (5.632). P/E Ratio (29.326) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.004). Dividend Yield (0.003) settles around the average of (0.164) among similar stocks. P/S Ratio (3.124) is also within normal values, averaging (3.643).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock slightly better than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VRBCF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Industry PharmaceuticalsMajor
A.I.dvisor indicates that over the last year, VRBCF has been loosely correlated with RCDTF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if VRBCF jumps, then RCDTF could also see price increases.
Ticker / NAME | Correlation To VRBCF | 1D Price Change % | ||
---|---|---|---|---|
VRBCF | 100% | N/A | ||
RCDTF - VRBCF | 56% Loosely correlated | N/A | ||
OGN - VRBCF | 1% Poorly correlated | +0.82% | ||
MIRA - VRBCF | 1% Poorly correlated | -0.94% | ||
CSWYF - VRBCF | 0% Poorly correlated | N/A | ||
JCRRF - VRBCF | -0% Poorly correlated | N/A | ||
More |